{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:27:06Z","timestamp":1771860426808,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Immune thrombocytopenic purpura is a condition associated with an unusual, unexplained, and sometimes very severe reduction in the level of platelets in the blood. Though documented, its association with Graves\u2019 disease is not very common and can easily be missed or misdiagnosed, leading to excessive bleeding and mortality. Treatment with steroids and antithyroid medications has been shown to be beneficial in correcting thrombocytopenia in these patients, although the response is varied. We report on a patient with Graves\u2019 disease who presents with immune thrombocytopenic purpura.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 37-year-old Ghanaian female presented to our hospital\u2019s emergency department with a complaint of palpitations, difficulty breathing, easy fatigue, and headaches. She had been referred from a peripheral hospital as a case of thrombocytopenia, severe anemia, and anterior neck swelling. She was diagnosed with Graves\u2019 disease 2\u00a0years ago, became euthyroid during treatment, but defaulted. On further examination and investigation, she was diagnosed with immune thrombocytopenic purpura and was also found to have elevated free T3 and T4, and suppressed thyroid stimulating hormone. She also had high thyroid autoantibodies. She was initially started on oral prednisolone but there was no stabilization of platelets until methimazole was introduced, which improved and normalized her platelet count.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The association of Graves\u2019 disease with immune thrombocytopenic purpura, though documented, is uncommon, and very few cases have been reported thus far. There have not been any reported cases in Ghana or Sub-Saharan Africa and hence, clinicians should be aware of this association when investigating immune thrombocytopenic purpura and should consider Graves\u2019 disease as a possible cause. From this study, we observed that there was no improvement in platelet count following the use of corticosteroid therapy until methimazole was started.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-03869-2","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:03:14Z","timestamp":1680652994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Graves\u2019 disease-induced immune thrombocytopenic purpura in an African female: a case report"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8184-7569","authenticated-orcid":false,"given":"Kwabena Oteng","family":"Agyapong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aba A.","family":"Folson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Fiador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Kootin-Sanwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Tufuor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally Afua","family":"Bampoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrietta","family":"Fiscian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Wonkyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"3869_CR1","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1111\/trf.16368","volume":"61","author":"T Kewan","year":"2021","unstructured":"Kewan T, Gunaratne TN, Mushtaq K, et\u00a0al. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience. Transfusion. 2021;61:2014.","journal-title":"Transfusion"},{"key":"3869_CR2","doi-asserted-by":"crossref","unstructured":"Immune thrombocytopenic purpura. Cines DB, Blanchette VS.N Engl J Med. 2002;346(13):995.\u00a0Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, USA.\u00a0PMID 11919310.","DOI":"10.1056\/NEJMra010501"},{"key":"3869_CR3","doi-asserted-by":"crossref","unstructured":"Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113: 6511\u20136521.\u00a0https:\/\/goo.gl\/gFDGy7.","DOI":"10.1182\/blood-2009-01-129155"},{"key":"3869_CR4","unstructured":"Audia S, Rossato M, Trad M, Samson M, Santegoets et\u00a0al. B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia. J Autoimmunity 2016;11.002. https:\/\/goo.gl\/BbV1xJ."},{"key":"3869_CR5","doi-asserted-by":"publisher","unstructured":"Lu J. Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia. Experimental and Therapeutic Medicine. 2013. https:\/\/doi.org\/10.3892\/etm.2013.1386. https:\/\/goo.gl\/txTmSC.","DOI":"10.3892\/etm.2013.1386"},{"key":"3869_CR6","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","volume":"358","author":"GA Brent","year":"2008","unstructured":"Brent GA. Graves\u2019 disease. N Engl J Med. 2008;358:2594\u2013605. https:\/\/doi.org\/10.1056\/NEJMcp0801880.","journal-title":"N Engl J Med"},{"key":"3869_CR7","volume-title":"Graves disease. StatPearls","author":"B Pokhrel","year":"2019","unstructured":"Pokhrel B, Bhusal K. Graves disease. StatPearls. Treasure Islands: StatPearls Publishing; 2019."},{"issue":"6","key":"3869_CR8","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.hoc.2009.08.003","volume":"23","author":"E Cheung","year":"2009","unstructured":"Cheung E, Liebman HA. Thyroid disease in patients with immune thrombocytopenia. Hematol Oncol Clin North AM. 2009;23(6):1251\u201360. https:\/\/doi.org\/10.1016\/j.hoc.2009.08.003.","journal-title":"Hematol Oncol Clin North AM"},{"key":"3869_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2324709616647085","volume":"4","author":"H Tahir","year":"2016","unstructured":"Tahir H, Sheraz F, Sagi J, Daruwalla V. Immune thrombocytopenia (ITP) secondary to subclinical Hashimoto\u2019s thyroiditis: role of levothyroxine in improving the clinical outcome of ITP. J Invest Med High Impact Case Rep. 2016;4:1\u20134. https:\/\/doi.org\/10.1177\/2324709616647085.","journal-title":"J Invest Med High Impact Case Rep"},{"key":"3869_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00277-010-0983-4","volume":"90","author":"H Gill","year":"2011","unstructured":"Gill H, Hwang Y-Y, Tse E. Primary immune thrombocytopenia responding to antithyroid treatment in a patient with Graves\u2019 disease. Ann Hematol. 2011;90:223\u20134. https:\/\/doi.org\/10.1007\/s00277-010-0983-4.","journal-title":"Ann Hematol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-03869-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-03869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:05:33Z","timestamp":1680653133000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-03869-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3869"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-03869-2","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"assertion":[{"value":"27 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}